CHRISTINA STRAUSS: Open Payments
NPI 1558817130 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 31 payments from 11 companies in 2025. Trend: 2023 $153 · 2024 $765 · 2025 $1,567
Food & beverage: $999Consulting: $490Education: $78
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $536 |
| Janssen Biotech, Inc. | 7 | $531 |
| Caris MPI, Inc. | 4 | $104 |
| SpringWorks Therapeutics, Inc. | 2 | $96 |
| Astellas Pharma US Inc | 3 | $73 |
| Gilead Sciences, Inc. | 2 | $50 |
| BeiGene USA, Inc. | 1 | $48 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $41 |
| Aveo Pharmaceuticals, Inc. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
Products named: Lenvima, ERLEADA, RYBREVANT, MI CANCER SEEK, OGSIVEO, Padcev, Trodelvy, BRUKINSA.
Industry payments across CO — which companies pay providers there.
